New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 15 04:00PM ET
0.4140
Dollar change
-0.0060
Percentage change
-1.43
%
Index- P/E- EPS (ttm)-1.08 Insider Own52.22% Shs Outstand41.61M Perf Week-19.05%
Market Cap17.23M Forward P/E- EPS next Y-1.16 Insider Trans0.00% Shs Float19.88M Perf Month25.38%
Enterprise Value-37.14M PEG- EPS next Q-0.24 Inst Own29.12% Short Float1.74% Perf Quarter65.40%
Income-48.19M P/S20.27 EPS this Y27.44% Inst Trans-3.49% Short Ratio0.12 Perf Half Y-55.96%
Sales0.85M P/B0.32 EPS next Y-19.95% ROA-61.25% Short Interest0.35M Perf YTD-56.87%
Book/sh1.30 P/C0.32 EPS next 5Y- ROE-67.28% 52W High1.54 -73.12% Perf Year-71.05%
Cash/sh1.31 P/FCF- EPS past 3/5Y3.21% -19.41% ROIC-89.11% 52W Low0.22 88.10% Perf 3Y-95.36%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin85.38% Volatility17.70% 14.15% Perf 5Y-
Dividend TTM- EV/Sales-43.69 EPS Y/Y TTM42.38% Oper. Margin-5940.92% ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio14.68 Sales Y/Y TTM- Profit Margin-5682.19% RSI (14)55.85 Recom2.50
Dividend Gr. 3/5Y- - Current Ratio14.68 EPS Q/Q54.83% SMA2013.29% Beta-1.17 Target Price1.00
Payout- Debt/Eq0.00 Sales Q/Q- SMA5020.75% Rel Volume0.51 Prev Close0.42
Employees25 LT Debt/Eq0.00 EarningsMay 08 BMO SMA200-42.25% Avg Volume2.80M Price0.41
IPOJul 29, 2021 Option/ShortNo / Yes EPS/Sales Surpr.19.23% - Trades Volume1,429,899 Change-1.43%
Date Action Analyst Rating Change Price Target Change
Apr-09-25Downgrade H.C. Wainwright Buy → Neutral
May-15-24Downgrade JP Morgan Overweight → Neutral
Feb-07-24Downgrade Jefferies Buy → Hold $7 → $1.50
Apr-17-23Initiated H.C. Wainwright Buy $18
Apr-10-23Initiated Wedbush Outperform $17
Dec-09-22Initiated JP Morgan Overweight $21
Feb-22-22Initiated JMP Securities Mkt Outperform $32
Aug-23-21Initiated Jefferies Buy $20
Aug-23-21Initiated Evercore ISI Outperform $40
Aug-23-21Initiated Cowen Outperform
Jul-09-25 11:56AM
08:16AM
07:18AM
Jul-08-25 01:28PM
08:00AM
08:00AM Loading…
08:00AM
Jul-07-25 09:00AM
Jun-12-25 08:00AM
May-08-25 08:00AM
Apr-29-25 08:00AM
Apr-09-25 10:58AM
07:21AM
Apr-08-25 08:00AM
05:27AM
Mar-13-25 08:00AM
08:00AM Loading…
Feb-25-25 08:00AM
Feb-12-25 05:29AM
Feb-11-25 08:00AM
Jan-10-25 08:00AM
Dec-10-24 08:00AM
Dec-06-24 06:48AM
Dec-02-24 08:00AM
Nov-27-24 08:00AM
Nov-26-24 08:00AM
Nov-25-24 08:00AM
Nov-22-24 07:01AM
Nov-21-24 08:00AM
Nov-07-24 08:00AM
Nov-05-24 02:59AM
Oct-29-24 08:00AM
08:00AM Loading…
Sep-30-24 08:00AM
Sep-23-24 08:00AM
Sep-10-24 08:00AM
Sep-09-24 05:15PM
Aug-29-24 08:00AM
Aug-27-24 08:00AM
Aug-14-24 12:00PM
Aug-08-24 08:00AM
Jul-09-24 08:00AM
Jun-17-24 08:00AM
May-31-24 07:00AM
May-10-24 06:30AM
May-09-24 01:54PM
10:14AM
08:00AM
May-07-24 08:00AM
Apr-17-24 04:01PM
Apr-12-24 10:23AM
Apr-11-24 07:43AM
Apr-10-24 04:01PM
01:01PM
Apr-01-24 10:05AM
Mar-12-24 08:00AM
Feb-26-24 08:00AM
Feb-06-24 09:46AM
08:00AM
Jan-04-24 08:00AM
Dec-20-23 08:00AM
Dec-09-23 12:00PM
Nov-28-23 07:00AM
Nov-09-23 08:00AM
Nov-08-23 08:00AM
Nov-02-23 09:15AM
Oct-03-23 08:00AM
Sep-03-23 12:00PM
Aug-31-23 08:00AM
Aug-08-23 08:00AM
Aug-02-23 08:00AM
Jul-11-23 08:00AM
Jun-29-23 07:00AM
Jun-24-23 03:30PM
Jun-09-23 09:15AM
Jun-01-23 08:00AM
May-29-23 09:55AM
May-12-23 09:55AM
May-09-23 08:00AM
May-08-23 08:00AM
Apr-06-23 08:00AM
Apr-03-23 08:00AM
Mar-15-23 09:15AM
Mar-10-23 09:35AM
Mar-06-23 02:49PM
08:00AM
07:30AM
Mar-02-23 09:01AM
Mar-01-23 08:00AM
Feb-27-23 07:00AM
Jan-31-23 04:05PM
Jan-05-23 08:00AM
Dec-15-22 08:00AM
Dec-14-22 06:39AM
Dec-12-22 05:55PM
Dec-01-22 07:00AM
Nov-29-22 08:00AM
Nov-17-22 05:39AM
Nov-11-22 08:00AM
Nov-10-22 11:51PM
09:15AM
Nov-07-22 08:00AM
07:30AM
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.